Bluejay Diagnostics, Inc. cotiza a 0.83 USD y tiene una capitalización bursátil de $4M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Bluejay Diagnostics, Inc. operates as a medical diagnostics company. It offers Symphony technology platform which consists of an analyzer and single-use protein detection cartridges that are designed to provide measurements of key diagnostic biomarkers found in blood; and Symphony analyzer used to orchestrate sample pr…
| Periodo | 2024-03 | 2023-11 | 2023-08 |
|---|---|---|---|
| Real | $-2848.00 | $-3328.00 | $-4400.00 |
| Estimado | $-1360.00 | $-1344.00 | $-2240.00 |
| Sorpresa | -109.4% | -147.6% | -96.4% |
| Métrica | BJDX | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -114.6% | -40.4% | -74.2% |
| ROA | -96.2% | -32.0% | -64.2% |
| Current Ratio | 4.88 | 2.84 | +2.04 |
| Debt / Equity | — | 0.28 | — |